Tuanxiang Pharmaceutical Overview
- Year Founded
-
2022
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
3
Tuanxiang Pharmaceutical General Information
Description
Developer of molecular glue and liquid-liquid phase separation technology designed for undruggable targets and refractory diseases. The company is engaged in new drug research and development, utilizing globally leading and unique phase separation technology, which focuses on undruggable targets and refractory diseases, thereby enabling patients to receive advanced treatment.
Contact Information
Corporate Office
- 9th Floor, Number 2, Lane 88
- Shengrong Road
- Shanghai, 201210
- China
Corporate Office
- 9th Floor, Number 2, Lane 88
- Shengrong Road
- Shanghai, 201210
- China
Tuanxiang Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 23-Jan-2025 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 07-Jan-2025 | Completed | Generating Revenue |
Tuanxiang Pharmaceutical Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Pudong Capital | Venture Capital | Minority | ||
| Hangzhou Chaosheng Investment Management | Growth/Expansion | Minority | ||
| Proxima Capital | Venture Capital | Minority |
Tuanxiang Pharmaceutical FAQs
-
When was Tuanxiang Pharmaceutical founded?
Tuanxiang Pharmaceutical was founded in 2022.
-
Where is Tuanxiang Pharmaceutical headquartered?
Tuanxiang Pharmaceutical is headquartered in Shanghai, China.
-
What industry is Tuanxiang Pharmaceutical in?
Tuanxiang Pharmaceutical’s primary industry is Drug Discovery.
-
Is Tuanxiang Pharmaceutical a private or public company?
Tuanxiang Pharmaceutical is a Private company.
-
What is Tuanxiang Pharmaceutical’s current revenue?
The current revenue for Tuanxiang Pharmaceutical is .
-
Who are Tuanxiang Pharmaceutical’s investors?
Pudong Capital, Hangzhou Chaosheng Investment Management, and Proxima Capital have invested in Tuanxiang Pharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process